/
MIRA
$0.95-$0.06 (-5.99%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$42.4M
42M shares
52-week range
$0.90 – $2.45
3% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Borrow rate
2.18%
Moderate
Price (6 mo)
Loading chart…
Change$-6.47
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — |
| R&D | $14.6K | $684.4K | $2.4M | $1.6M | $3.3M | $1.7M |
| Operating income | −$67.6K | −$2.2M | −$7.0M | −$8.5M | −$8.0M | −$10.5M |
| EBITDA | −$67.6K | $0 | $0 | −$8.5M | −$8.0M | −$10.4M |
| Net income | −$68.0K | −$2.2M | −$7.1M | −$12.0M | −$7.9M | −$10.4M |
| Net margin | — | — | — | — | — | — |
| EPS (diluted) | -0.00 | -0.15 | -0.48 | -0.65 | -0.51 | -1.35 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $276M | $-0.18 | $-0.18–$-0.18 | 1 |
| 2027 | $40M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.26
Price
$0.95
Implied downside
-72%
Peer comparison
MIRA Pharmaceuticals, Inc. Common Stock
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
www.mirapharmaceuticals.com- Employees
- 2
- IPO / List date
- Aug 3, 2023
- HQ
- MIAMI, FL
Held by traders on TradeandTell
No one on the platform currently holds MIRA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-09-30 | 46,700 | $63.5K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded MIRA yet.
